Clinical advantages of dual activity in allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 64, 2000, Pages 34-39

  Horak, F ^a,b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antihistamines; Mizolastine; Perennial allergic rhinitis; Seasonal allergic rhinitis

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR; LORATADINE; MIZOLASTINE; PLACEBO;

ALLERGIC RHINITIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; EXTRAVASATION; HUMAN; NOSE OBSTRUCTION; NOSE SECRETION; PRIORITY JOURNAL; PRURITUS; RHINORRHEA; SNEEZING; TREATMENT OUTCOME;

EID: 0034517226     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00805.x     Document Type: Conference Paper

References (13)

1. Prospective epidemiological longitudinal study in allergic diseases
2. Allergic rhinitis and asthma: How important is the link?
3. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire
4. Pathogenesis of allergic rhinitis
5. International Consensus Report on Diagnosis and Management of Rhinitis
6. Inhibitory effect of mizolastine on 5-lipoxygenase
7. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: Effect of mizolastine
8. Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis
9. Seasonal allergic rhinitis (SAR): A pooling of mizolastine trials
10. Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
11. Mizolastine therapy has an effect on nasal blockage in perennial allergic rhinitis
12. Mizolastine is effective and well tolerated in the long-term treatment of perennial allergic rhinoconjunctivitis
13. Placebo controlled study of mizolastine 10 mg and loratadine 10 mg once daily in perennial allergic rhinitis (PAR)